Infantile Spasm
9
3
4
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
11.1%
1 terminated out of 9 trials
66.7%
-19.8% vs benchmark
22%
2 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Treatment of Refractory Infantile Spasms With Fenfluramine
The Effect of Spa and Massage on Babies on Colic Symptoms
Characterization by Automated System on Infantile Spasmes
Tricaprilin Infantile Spasms Pilot Study
Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome
A Study to Assess Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile Spasms
Vigabatrin With High Dose Prednisolone Combination Therapy vs Vigabatrin Alone for Infantile Spasm
A Novel Approach to Infantile Spasms
Intravenous Methylprednisolone Versus Oral Prednisolone for Infantile Spasms